Authors: Liu M; Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China., Wei X; Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China., Zheng Z; Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China., Li Y; Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China., Li M; Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China., Lin J; Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China., Yang L; Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Source: International journal of nanomedicine [Int J Nanomedicine] 2023 Mar 27; Vol. 18, pp. 1537-1560. Date of Electronic Publication: 2023 Mar 27 (Print Publication: 2023).
Publication Type: Journal Article; Review
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE
Authors: Ding L; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China., Wang X; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China., Wang T; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China., Yu B; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China., Han M; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China., Guo Y; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China.; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100093, China.; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China.
Source: Molecules (Basel, Switzerland) [Molecules] 2022 Dec 21; Vol. 28 (1). Date of Electronic Publication: 2022 Dec 21.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
Authors: Zhao YP; Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China.; Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, China., Han JF; Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China.; Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, China., Zhang FY; Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China., Liao TT; Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China., Na R; Department of Epidemiology and Health Statistics, Faculty of Military Preventive Medicine, Fourth Military Medical University, Xi'an, China., Yuan XF; Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China., He GB; Department of Ultrasound Diagnosis, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Ye W; Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China.
Source: Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 2269-2282.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE
Authors: Yan Y; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Lu A; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Dou Y; Department of Sports Medicine, Peking University Third Hospital, Beijing, 100191, China., Zhang Z; Department of Sports Medicine, Peking University Third Hospital, Beijing, 100191, China., Wang XY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Zhai L; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Ai LY; Department of Sports Medicine, Peking University Third Hospital, Beijing, 100191, China., Du MZ; Department of Sports Medicine, Peking University Third Hospital, Beijing, 100191, China., Jiang LX; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Zhu YJ; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Shi YJ; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Liu XY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Jiang D; Department of Sports Medicine, Peking University Third Hospital, Beijing, 100191, China., Wang JC; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.; Laboratory of Innovative Formulations and Pharmaceutical Excipients, Ningbo Institute of Marine Medicine, Peking University, Beijing, 315832, China.
Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Apr; Vol. 10 (11), pp. e2207490. Date of Electronic Publication: 2023 Feb 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
MeSH Terms: Nitric Oxide*/metabolism , Osteoarthritis*/therapy , Osteoarthritis*/metabolism , Nanoparticle Drug Delivery System*/pharmacology , Carbonic Anhydrase IX*/drug effects , Carbonic Anhydrase IX*/metabolism, Animals ; Mice ; Rats ; Macrophages/drug effects ; Macrophages/metabolism ; Nanomedicine/methods ; RNA, Messenger/metabolism ; Synovial Membrane/metabolism ; Cellular Reprogramming/drug effects
Authors: Li Y; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Zhang Z; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Huang J; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Xing H; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Wang L; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Huang L; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Sui X; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Luo Y; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Shen L; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Wang Y; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com., Yang J; State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Beijing, 100850, China. ajaway@126.com.
Source: Nanoscale [Nanoscale] 2023 Mar 09; Vol. 15 (10), pp. 4852-4862. Date of Electronic Publication: 2023 Mar 09.
Publication Type: Journal Article
Journal Info: Publisher: RSC Pub Country of Publication: England NLM ID: 101525249 Publication Model: Electronic Cited Medium: Internet ISSN: 2040-3372 (Electronic) Linking ISSN: 20403364 NLM ISO Abbreviation: Nanoscale Subsets: MEDLINE
MeSH Terms: Nanoparticle Drug Delivery System* , Oximes*, Antidotes/chemistry ; Antidotes/pharmacology ; Brain ; Phospholipases A2
Authors: Guan Q; Key Laboratory of Basic and Application Research of Beiyao (118437Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China., Zhou X; Key Laboratory of Basic and Application Research of Beiyao (118437Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China., Yang F; Key Laboratory of Basic and Application Research of Beiyao (118437Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China., Zhang X; Key Laboratory of Basic and Application Research of Beiyao (118437Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China., Wang Y; Key Laboratory of Basic and Application Research of Beiyao (118437Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China., Li W; Key Laboratory of Basic and Application Research of Beiyao (118437Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China., Li X; Key Laboratory of Basic and Application Research of Beiyao (118437Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Source: Journal of biomaterials applications [J Biomater Appl] 2023 Mar; Vol. 37 (8), pp. 1393-1408. Date of Electronic Publication: 2022 Nov 12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 8813912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-8022 (Electronic) Linking ISSN: 08853282 NLM ISO Abbreviation: J Biomater Appl Subsets: MEDLINE
MeSH Terms: Hepatitis B virus* , Nanoparticle Drug Delivery System*, Liver/pathology ; Acids
Authors: Subramanian DA; Department of Chemical Engineering and David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Langer R; Department of Chemical Engineering and David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Traverso G; Department of Chemical Engineering and David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. cgt20@mit.edu.
Source: Journal of nanobiotechnology [J Nanobiotechnology] 2022 Aug 06; Vol. 20 (1), pp. 362. Date of Electronic Publication: 2022 Aug 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE
Authors: Tian C; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, People's Republic of China.; Chinese People's Liberation Army 210 Hospital, 116021, Dalian, People's Republic of China., Zheng S; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, People's Republic of China., Liu X; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, People's Republic of China., Kamei KI; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, People's Republic of China. kamei.kenichiro.7r@kyoto-u.ac.jp.; Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, 606-8501, Kyoto, Japan. kamei.kenichiro.7r@kyoto-u.ac.jp.
Source: Journal of nanobiotechnology [J Nanobiotechnology] 2022 Jul 20; Vol. 20 (1), pp. 338. Date of Electronic Publication: 2022 Jul 20.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE
Authors: Qin A; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China., Chen S; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China., Li S; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China., Li Q; Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China., Huang X; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China., Xia L; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China., Lin Y; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China., Shen A; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China. shenao@gzhmu.edu.cn., Xiang AP; Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou, 510080, China. xiangp@mail.sysu.edu.cn., Zhang L; Key Laboratory of Molecular Target and Clinical Pharmacology and the State and NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China. zhanglm@gzhmu.edu.cn.
Source: Journal of nanobiotechnology [J Nanobiotechnology] 2022 Jul 16; Vol. 20 (1), pp. 335. Date of Electronic Publication: 2022 Jul 16.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE
Authors: Ma Q; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Inno Medicine Co. Ltd., Beijing, 100195, P. R. China., Wu S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China., Yang L; Beijing Inno Medicine Co. Ltd., Beijing, 100195, P. R. China., Wei Y; Beijing Inno Medicine Co. Ltd., Beijing, 100195, P. R. China., He C; Beijing Inno Medicine Co. Ltd., Beijing, 100195, P. R. China., Wang W; Beijing Inno Medicine Co. Ltd., Beijing, 100195, P. R. China., Zhao Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, 100029, P. R. China., Wang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, 100029, P. R. China., Yang S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, 100029, P. R. China., Shi D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, 100029, P. R. China., Liu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, 100029, P. R. China., Zhou Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, 100029, P. R. China., Sun J; Beijing Inno Medicine Co. Ltd., Beijing, 100195, P. R. China., Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, P. R. China.; Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, P. R. China.; Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, 100029, P. R. China.
Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Feb; Vol. 10 (5), pp. e2202416. Date of Electronic Publication: 2022 Dec 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
MeSH Terms: Atherosclerosis*/diagnostic imaging , Atherosclerosis*/drug therapy , Plaque, Atherosclerotic*/diagnostic imaging , Plaque, Atherosclerotic*/drug therapy , Plaque, Atherosclerotic*/pathology , Nanoparticle Drug Delivery System*/pharmacology , Nanoparticle Drug Delivery System*/therapeutic use, Animals ; Mice ; Hyaluronic Acid/therapeutic use ; Magnetic Resonance Imaging
Authors: Liu X; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China., Liu J; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China., Xu S; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China., Li X; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China., Wang Z; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China., Gao X; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China., Tang B; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China., Xu K; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Shandong Normal University, Jinan 250014, P. R. China.
Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2023 Jan 18; Vol. 15 (2), pp. 2529-2537. Date of Electronic Publication: 2023 Jan 03.
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-8252 (Electronic) Linking ISSN: 19448244 NLM ISO Abbreviation: ACS Appl Mater Interfaces Subsets: MEDLINE
MeSH Terms: Metal Nanoparticles*/chemistry , Resveratrol*/pharmacology , Resveratrol*/therapeutic use , Triple Negative Breast Neoplasms*/drug therapy , Nanoparticle Drug Delivery System*/pharmacology , Nanoparticle Drug Delivery System*/therapeutic use, Animals ; Mice ; Drug Carriers/chemistry ; Drug Delivery Systems/methods ; Gold/chemistry ; Hydrogen Peroxide ; Nanoparticles/chemistry ; Peptides/chemistry ; Porosity ; Silicon Dioxide/chemistry ; Selenium/chemistry
Authors: Anzengruber M; University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria., Wimmer L; University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria., Szuchar R; University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria., Skoll K; University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria., Wirth M; University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria., Gabor F; University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria. Electronic address: franz.gabor@univie.ac.at.
Source: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Jan 01; Vol. 180, pp. 106330. Date of Electronic Publication: 2022 Nov 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE
MeSH Terms: Gemcitabine*/administration & dosage , Gemcitabine*/analogs & derivatives , Gemcitabine*/chemistry , Urinary Bladder Neoplasms*/drug therapy , Wheat Germ Agglutinins*/chemistry , Antimetabolites, Antineoplastic*/administration & dosage , Antimetabolites, Antineoplastic*/chemistry , Nanoparticle Drug Delivery System*/administration & dosage , Nanoparticle Drug Delivery System*/chemistry, Humans ; Administration, Intravesical ; Cell Line, Tumor ; Deoxycytidine/administration & dosage ; Polylactic Acid-Polyglycolic Acid Copolymer/chemistry
Authors: Naki T; Department of Chemistry, University of Fort Hare, Alice, South Africa., Matshe WMR; Polymer and Composites, CSIR Materials Science and Manufacturing, Pretoria, South Africa., Balogun MO; Polymer and Composites, CSIR Materials Science and Manufacturing, Pretoria, South Africa., Sinha Ray S; DST/CSIR National Centre for Nanostructured Materials, Council for Scientific and Industrial Research, Pretoria, South Africa., Egieyeh SA; School of Pharmacy, University of the Western Cape, Bellville Cape Town., Aderibigbe BA; Department of Chemistry, University of Fort Hare, Alice, South Africa.
Source: Journal of microencapsulation [J Microencapsul] 2023 Jan; Vol. 40 (1), pp. 15-28. Date of Electronic Publication: 2023 Jan 19.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8500513 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5246 (Electronic) Linking ISSN: 02652048 NLM ISO Abbreviation: J Microencapsul Subsets: MEDLINE
MeSH Terms: Alzheimer Disease*/drug therapy , Nanoparticle Drug Delivery System*/chemistry , Nanoparticle Drug Delivery System*/pharmacology , Nanoparticle Drug Delivery System*/therapeutic use, Humans ; Cholinesterase Inhibitors/pharmacology ; Cholinesterase Inhibitors/therapeutic use ; Cholinesterase Inhibitors/chemistry ; Memantine/chemistry ; Memantine/pharmacology ; Memantine/therapeutic use ; Tacrine/pharmacology ; Tacrine/chemistry ; Tacrine/therapeutic use ; Polymers/chemistry ; Polymers/pharmacology ; Polymers/therapeutic use
Authors: Enayati A; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Rezaei A; Department of Food Science and Technology, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Falsafi SR; Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran., Rostamabadi H; Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran., Malekjani N; Department of Food Science and Technology, Faculty of Agricultural Sciences, University of Guilan, Rasht, Iran., Akhavan-Mahdavi S; Faculty of Food Science and Technology, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran., Kharazmi MS; Faculty of Medicine, University of California, Riverside, USA., Jafari SM; Faculty of Food Science and Technology, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran; Universidade de Vigo, Nutrition and Bromatology Group, Department of Analytical Chemistry and Food Science, Faculty of Science, E-32004 Ourense, Spain; College of Food Science and Technology, Hebei Agricultural University, Baoding 071001, China. Electronic address: smjafari@gau.ac.ir.
Source: Food chemistry [Food Chem] 2023 Jun 30; Vol. 412, pp. 135479. Date of Electronic Publication: 2023 Jan 16.
Publication Type: Review; Journal Article
Journal Info: Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 7702639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7072 (Electronic) Linking ISSN: 03088146 NLM ISO Abbreviation: Food Chem Subsets: MEDLINE
MeSH Terms: Nanoparticle Drug Delivery System* , Nanostructures*, Carotenoids/chemistry ; Lipids
Authors: Shi P; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Cheng Z; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhao K; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Chen Y; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhang A; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Gan W; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhang Y; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. zhangyukuncom@126.com.
Source: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Mar 22; Vol. 21 (1), pp. 103. Date of Electronic Publication: 2023 Mar 22.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE
Authors: Yan C; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China., Li Q; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China., Sun Q; Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China., Yang L; Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China., Liu X; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China., Zhao Y; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China., Shi M; School of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China., Li X; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China., Luo K; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Source: International journal of nanomedicine [Int J Nanomedicine] 2023 Mar 10; Vol. 18, pp. 1195-1218. Date of Electronic Publication: 2023 Mar 10 (Print Publication: 2023).
Publication Type: Journal Article; Review
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE
Authors: Wu F; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Chen PM; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Gardinier TC; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Turker MZ; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Venkatesan AM; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Patel V; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Khor T; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Bradbury MS; Department of Radiology, Sloan Kettering Institute for Cancer Research, New York, New York 10065, United States.; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, New York, New York 10065, United States., Wiesner UB; Materials Science and Engineering, Cornell University, Ithaca, New York 14850, United States.; Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York 14853, United States., Adams GP; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Germano G; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Chen F; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States., Ma K; Elucida Oncology Inc., Monmouth Junction, New Jersey 08852, United States.
Source: ACS nano [ACS Nano] 2022 Dec 27; Vol. 16 (12), pp. 20021-20033. Date of Electronic Publication: 2022 Oct 20.
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-086X (Electronic) Linking ISSN: 19360851 NLM ISO Abbreviation: ACS Nano Subsets: MEDLINE
MeSH Terms: Folate Receptor 1*/metabolism , Folate Receptor 1*/therapeutic use , Neoplasms*/drug therapy , Nanoparticle Drug Delivery System*, Animals ; Humans ; Mice ; Cell Line, Tumor ; Disease Models, Animal ; Folic Acid/chemistry ; Nanoparticles/therapeutic use ; Silicon Dioxide/therapeutic use
Authors: Al Sariri T; School of Mathematics and Statistics, University of Glasgow, University Place, Glasgow, G12 8QQ, UK, Department of Mathematics, College of Science, Sultan Qaboos University, Al-Khoudh 123, Oman., Penta R; School of Mathematics and Statistics, University of Glasgow, University Place, Glasgow, G12 8QQ, UK.
Source: Mathematical medicine and biology : a journal of the IMA [Math Med Biol] 2022 Dec 02; Vol. 39 (4), pp. 332-367.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Published for the Institute of Mathematics and its Applications by Oxford University Press Country of Publication: England NLM ID: 101182345 Publication Model: Print Cited Medium: Internet ISSN: 1477-8602 (Electronic) Linking ISSN: 14778599 NLM ISO Abbreviation: Math Med Biol Subsets: MEDLINE
MeSH Terms: Neoplasms*/drug therapy , Nanoparticle Drug Delivery System*/pharmacokinetics, Humans ; Diffusion ; Hot Temperature ; Nanoparticles/chemistry
Authors: Wang L; Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China., Zhao C; Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China., Lu L; Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China., Jiang H; Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China., Wang F; Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China., Zhang X; Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmacology, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 28; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 28.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
MeSH Terms: Paclitaxel*/administration & dosage , Prodrugs*/administration & dosage , Triple Negative Breast Neoplasms*/drug therapy , Nanoparticle Drug Delivery System*/administration & dosage , Oligopeptides*/administration & dosage, Humans ; Cell Line, Tumor ; Nanoparticles/administration & dosage
Authors: Zhang Z; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China., Xu D; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China., Wang J; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China., Zhang R; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China., Du H; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China., Zhou T; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China., Wang X; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China., Wang F; College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Source: Biomacromolecules [Biomacromolecules] 2023 Jan 09; Vol. 24 (1), pp. 439-448. Date of Electronic Publication: 2022 Dec 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 100892849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4602 (Electronic) Linking ISSN: 15257797 NLM ISO Abbreviation: Biomacromolecules Subsets: MEDLINE
MeSH Terms: DNA*/chemistry , Doxorubicin* , Nanoparticle Drug Delivery System*/chemistry, Animals ; Mice ; Cell Line, Tumor ; Drug Delivery Systems/methods ; Genetic Therapy/methods ; Melanoma/drug therapy ; Melanoma/genetics ; RNA, Small Interfering ; Nanoparticles/chemistry